Device type · QVA
Fludeoxyglucose F18-Guided Radiation Therapy System
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QVA
Radiology
Device class
Class II
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
32
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Fludeoxyglucose F18-Guided Radiation Therapy System
- Product code
- QVA
- Device class
- Class II
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5060
- Specialty
- Radiology & Imaging
- FDA record
- Classification database entry for QVA
Latest FDA decisions
K252071 · Decided Dec 18, 2025 · 170 days after receipt
Device type: Fludeoxyglucose F18-Guided Radiation Therapy System (QVA) · Radiology & Imaging
- RefleXion Medical Radiotherapy System (RMRS)New device typeBreakthroughDe Novo
DEN220014 · Decided Feb 1, 2023 · 343 days after receipt
Device type: Fludeoxyglucose F18-Guided Radiation Therapy System (QVA) · Radiology & Imaging
Reports received
32
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
11
34% of reports
Injury reports
21
66% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 2 | 0 | 0 |
| Jun 25 | 6 | 0 | 0 | 0 |
| Jul 25 | 1 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 11 | 0 | 0 | 0 |
| Apr 26 | 0 | 21 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Program or Algorithm Execution Problem32
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Insufficient Information32
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1656-2026 · Started Feb 9, 2026 · Posted by FDA Mar 27, 2026
Reason given: Due to a radiotherapy medical system software defect, when performing angular roll corrections followed by a repeat localization, the roll corrections applied in the initial localization scan are not carried through to treatment delivery leading to the treatment plan dose being delivered to the incorrect location,...
Cause as FDA categorized it: Software change control
Z-2486-2025 · Started Jul 22, 2025 · Posted by FDA Sep 2, 2025
Reason given: Due to incorrect software configuration that potentially allows more than two (2) fractions within a 12-hour period (fractionLimits) and could potentially lead to adverse events (toxicity).
Cause as FDA categorized it: Software change control
Z-1933-2024 · Started Apr 16, 2024 · Posted by FDA May 30, 2024
Reason given: A potential dose error exists for patients treated with an out of session SCINTIX partial fraction.
Cause as FDA categorized it: Software design
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.